Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole for Schizophrenia With Co-Morbid Social Anxiety
NCT00177008Phase 4Completed
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of aripiprazole in schizophrenia, schizoaffective disorder and Social Anxiety Disorder (SAD), sponsored by University of Medicine and Dentistry of New Jersey. Primary endpoints: Liebowitz Social Anxiety Scale, Sheehan Disability Scale and 1 more. Started Mar 2004; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophreniaschizoaffective disorderSocial Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00177008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00177008.